Little Green Pharma Reports Strong Operational Momentum with Record Cash Receipts and Positive Cash flow.

Little Green Pharma (ASX: LGP) reported a strong quarter ending 30 June 2025, achieving a net operating cash inflow of AU$0.5 million, reversing a previous outflow. The company recorded unaudited revenue of AU$9.1 million and record cash receipts of AU$12 million, driven by a near 50% year-on-year increase, particularly from Health House and European flower sales.

Annual financials for FY25 showed revenue of AU$36.8 million, with a 52% CAGR from FY22–FY25, net profit of AU$3.3 million, and adjusted EBITDA of AU$2.9 million. Sales from the Danish facility into Germany grew over 70%, while a newly commissioned 2.4tpa room boosted total production capacity to 8.5tpa. Preparations are underway for the Danish site to become a cannabis distribution hub under new laws effective January 2026. With AU$2.5 million in cash and AU$5 million in unused financing, LGP is well-positioned for continued expansion.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com